Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

ABBOTT LABORATORIES

(ABT)
  Report
Delayed Nyse  -  04:03 2022-12-05 pm EST
105.41 USD   -2.48%
12/02Reckitt expects U.S. infant formula shortage until spring
RE
12/01Reckitt expects U.S. infant formula shortage until spring
RE
12/01Enfamil maker Reckitt sees formula shortage continuing until Spring
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Business Summary
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows:

- diagnostic systems and instruments (36.3%);

- vascular devices (33.4%): endoprosthetic systems, dilation catheters, arterial closures, etc.;

- nutrition products (19.2%): pediatric nutrition products, nutritional supplements, and dietetic products;

- medicine (11%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.;

- other (0.1%).

Net sales are distributed geographically as follows: the United States (38.6%), Germany (6%), China (5.6%), Japan (3.9%), India (3.6%), Canada (3.2%), Switzerland ( 3.1%) and others (36%).

Number of employees : 113 000 people.
Sales per Business
20202021Delta
Diagnostic Products10 805.0031.2%15 644.0036.3% +44.78%
Medical Devices11 787.0034.1%14 367.0033.4% +21.89%
Nutritional Products7 647.0022.1%8 294.0019.3% +8.46%
Established Pharmaceutical Products4 303.0012.4%4 718.0011% +9.64%
Other66.000.2%52.000.1% -21.21%
USD in Million
Sales per region
20202021Delta
United States13 022.0037.6%16 642.0038.6% +27.8%
All Other Countries12 580.0036.3%15 515.0036% +23.33%
Germany2 108.006.1%2 572.006% +22.01%
China1 965.005.7%2 392.005.6% +21.73%
Japan1 386.004%1 695.003.9% +22.29%
India1 323.003.8%1 561.003.6% +17.99%
Canada--1 385.003.2%-
Switzerland1 140.003.3%1 313.003% +15.18%
USD in Million
Managers
Name Title Age Since
Robert Ford Chairman, President, Chief Executive Officer & COO 47 2021
Robert Funck Chief Financial Officer & Executive VP-Finance 60 2020
Sabina Ewing Chief Investment Officer, VP-Business & Technology 46 -
Scott Leinenweber Vice President-Investor Relations - 2015
Karen Peterson Treasurer & Vice President - 2015
Hubert L. Allen Secretary, Executive VP & General Counsel 55 2013
Melissa Brotz Vice President-Global Marketing & External Affairs - -
John M. Capek, Dr. Executive Vice President-Ventures 59 2015
David P. Mark Vice President-Internal Audit - -
Jim Leffelman Manager-Expense Reporting - -
Members of the board
Name Title Age Since
Robert Ford Chairman, President, Chief Executive Officer & COO 47 2021
Glenn Fletcher Tilton Independent Director 72 2007
William A. Osborn Lead Independent Director 73 -
Robert J. Alpern, Dr. Independent Director 70 2008
Sally E. Blount, Dr. Independent Director 59 2011
Nancy McKinstry Independent Director 62 2011
Daniel Starks Independent Director 66 2017
John Stratton Independent Director 60 2017
Michelle Kumbier Independent Director 53 -
Darren W. McDew Independent Director 60 -
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,985,919,440 1,730,768,825 87.2% 242,345,663 12.2% 87.2%
Shareholders
NameEquities%
The Vanguard Group, Inc. 147,534,252 8.42%
Capital Research & Management Co. 100,782,100 5.75%
Capital Research & Management Co. (Global Investors) 78,806,814 4.50%
SSgA Funds Management, Inc. 74,138,862 4.23%
Capital Research & Management Co. (International Investors) 52,232,376 2.98%
BlackRock Fund Advisors 36,988,478 2.11%
Geode Capital Management LLC 30,060,816 1.72%
Massachusetts Financial Services Co. 24,531,808 1.40%
Northern Trust Investments, Inc.(Investment Management) 24,051,485 1.37%
Norges Bank Investment Management 16,276,274 0.93%
Holdings
NameEquities%Valuation
ABBOTT INDIA LIMITED (500488) 15,934,048 75.0% 3,707,135,937 USD
ABBOTT LABORATORIES (PAKISTAN) LIMITED (ABOT) 76,259,454 77.9% 197,985,557 USD
ALLERGY THERAPEUTICS PLC (AGY) 240,584,571 35.4% 45,703,851 USD
DOMESCO MEDICAL IMPORT - EXPORT JOINT-STOCK CORPORATION (DMC) 17,948,800 51.7% 31,852,838 USD
Markets and indexes
- International Market
- S&P 100 / S&P 500, Stoxx Americas 100, Stoxx Global 200, Stoxx NorthAmerica 50, Stoxx USA 50
Stock Exchange Codes
- Bloomberg Code :  ABTT11B:BZ
- Reuters Code :  
- Datastream Code :  
Company contact information
Abbott Laboratories
100 Road
IL 60064-6400 Palatine, Illinois

Phone : +1 (224) 667 6400
Fax :
web site : https://www.abbott.com/investors.html
Brand Portfolio
In partnership withAllbrands.markets
More brands of Abbott Laboratories
Sector Other Medical Equipment, Supplies & Distribution
1st jan.Capi. (M$)
ABBOTT LABORATORIES-23.20%188 463
MEDTRONIC PLC-23.04%105 909
BECTON, DICKINSON AND COMPANY2.69%71 518
DEXCOM, INC.-12.01%45 621
HOYA CORPORATION-18.03%36 935
AMERISOURCEBERGEN CORPORATION30.93%35 785
SARTORIUS STEDIM BIOTECH-30.10%32 852
BAXTER INTERNATIONAL INC.-40.24%26 829
ZIMMER BIOMET HOLDINGS-1.21%25 806
TERUMO CORPORATION-17.37%22 139
INSULET CORPORATION13.67%21 394
FUJIFILM HOLDINGS CORPORATION-15.59%21 330
STERIS PLC-21.16%19 157
WEST PHARMACEUTICAL SERVICES, INC.-47.90%18 090
ALIGN TECHNOLOGY, INC.-71.41%15 498
AVANTOR, INC.-46.96%15 331
SYSMEX CORPORATION-45.56%13 089
BIO-RAD LABORATORIES, INC.-44.54%12 425
TELEFLEX INCORPORATED-28.22%11 379
REPLIGEN CORPORATION-32.56%10 330
FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED-26.25%8 859